SCHEMBL11998914

SCHEMBL11998914

O=c1[nH]c2ccc(Br)cc2n1-c1ccncn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT2 P31751 1/20 0.47
▸ CLK2 P49760 1/20 0.47
▸ DYRK1A Q13627 1/20 0.47
▸ CLK4 Q9HAZ1 1/20 0.47
▸ AURKA O14965 4/20 0.41
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ DAO P14920 1/20 0.36
▸ CHUK O15111 1/20 0.35
▸ HAVCR2 Q8TDQ0 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.34
▸ NLRP3 Q96P20 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19024354 0.82 AURKA (0.48) AKT2CLK2DYRK1ACLK4AURKA
SCHEMBL22191299 0.81 AKT2 (0.52) AKT2CLK2DYRK1ACLK4AURKA
SCHEMBL5956560 0.80 CDK5 (0.56) AURKACDK5CDK5R1DAOPOLB
SCHEMBL11971186 0.79 CDC7 (0.52) AKT2CLK2DYRK1ACLK4AURKA
SCHEMBL15553020 0.77 DAO (0.43) AURKACDK5CDK5R1DAOCHUK
SCHEMBL11340818 0.73 AKT2 (0.56) AKT2CLK2DYRK1ACLK4AURKA
SCHEMBL22191252 0.73 AKT2 (0.47) AKT2CLK2DYRK1ACLK4AURKA
SCHEMBL29437804 0.73 AKT2 (0.47) AKT2CLK2DYRK1ACLK4AURKA
SCHEMBL25768726 0.71 AURKA (0.51) CLK2DYRK1ACLK4AURKACDK5
SCHEMBL15396404 0.71 MEN1 (0.55) AKT2CLK2DYRK1ACLK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150038460-A1 6,5-Heterocyclic Propargylic Alcohol Compounds and Uses Therefor GENENTECH, INC. (US) 2015-02-05 — — US disclosed
US-8901313-B2 6,5-heterocyclic propargylic alcohol compounds and uses therefor GENENTECH, INC. (US) 2014-12-02 — — US disclosed
US-20120214762-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR GENENTECH, INC. (US) 2012-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214762-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR NFKB1, NFRKB, NFKBIA AKT2 457/4885CLK2 2374/4885DYRK1A 2084/4885
US-20150038460-A1 6,5-Heterocyclic Propargylic Alcohol Compounds and Uses Therefor NFKB1, NFRKB, NFKBIA AKT2 457/4885CLK2 2374/4885DYRK1A 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback